Clinical Trial of AVL-3288 in Schizophrenia Patients

Clinical trial NCT02978599 · COMPLETED

Trial details

NCT number: NCT02978599
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2016-11-01
Primary completion: 2018-10-26
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.